APP and Alzheimer disease: 5xFAD mice develop Aβ pathology earlier than other transgenic strains, such as Tg2576 (~ 3 months), TgSwDI (3 months), TgCRND8 (5 months), 3xTg-AD (6 months), or APP (V717I) mice (10 months) [6].